Загрузка...
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
With more than 80% of all diagnosed lung cancer cases, non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Exact diagnosis is mostly very late and advanced-stage NSCLCs are inoperable at admission. Tailored therapies with tyrosine kinase inhibitors are only availa...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777811/ https://ncbi.nlm.nih.gov/pubmed/29383199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22975 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|